Michelle B. Titunick

Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.

I. Zagon, P. McLaughlin, J. Sassani, 2017, Advances in wound care.

Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes

I. Zagon, P. McLaughlin, J. Sassani, 2019, BMC Ophthalmology.

Selective opioid growth factor receptor antagonists based on a stilbene isostere.

Jeffrey D. Neighbors, P. McLaughlin, Jessica M. Biegler, 2017, Bioorganic & medicinal chemistry.

Blockade of the OGF-OGFr pathway in diabetic bone

I. Zagon, P. McLaughlin, G. Lewis, 2019, Connective tissue research.

Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.

I. Zagon, P. McLaughlin, J. Sassani, 2017, Advances in wound care.